
TY  - JOUR
AU  - Vardi, Y.
AU  - Pedersen, C. Damsted
TI  - P-03 Female Sexual Health
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_3.x
DO  - doi:10.1111/j.1743-6109.2007.00390_3.x
SP  - 111
EP  - 114
PY  - 2007
ER  - 

TY  - JOUR
AU  - Marberger, M.
AU  - Briganti, A.
TI  - P-06 Erectile Dysfunction following Radical Prostatectomy
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_6.x
DO  - doi:10.1111/j.1743-6109.2007.00390_6.x
SP  - 121
EP  - 124
PY  - 2007
ER  - 

TY  - JOUR
AU  - Akkus, E.
AU  - Hatzimouratidis, K.
TI  - MP-02 Pharmacology
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_9.x
DO  - doi:10.1111/j.1743-6109.2007.00390_9.x
SP  - 133
EP  - 137
PY  - 2007
ER  - 

TY  - JOUR
TI  - Educational Opportunities
JO  - AORN Journal
JA  - AORN Journal
VL  - 58
IS  - 4
SN  - 0001-2092
UR  - https://doi.org/10.1016/S0001-2092(07)65286-7
DO  - doi:10.1016/S0001-2092(07)65286-7
SP  - 808
EP  - 811
PY  - 1993
ER  - 

TY  - JOUR
TI  - PP-03 Female Sexual Function and Dysfunction
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_15.x
DO  - doi:10.1111/j.1743-6109.2007.00390_15.x
SP  - 175
EP  - 182
PY  - 2007
ER  - 

TY  - JOUR
AU  - Buvat, J.
AU  - Waldkirch, E.
TI  - P-01 Hormones and Sexuality
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_1.x
DO  - doi:10.1111/j.1743-6109.2007.00390_1.x
SP  - 105
EP  - 108
PY  - 2007
ER  - 

TY  - JOUR
AU  - Corona, G.
AU  - Simonsen, U.
TI  - MP-03 Physiology and Pathophysiology
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_10.x
DO  - doi:10.1111/j.1743-6109.2007.00390_10.x
SP  - 138
EP  - 143
PY  - 2007
ER  - 

TY  - JOUR
TI  - PP-01 Pharmacology
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_13.x
DO  - doi:10.1111/j.1743-6109.2007.00390_13.x
SP  - 152
EP  - 161
PY  - 2007
ER  - 

TY  - JOUR
TI  - PP-04 Ejaculatory Disorders
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_16.x
DO  - doi:10.1111/j.1743-6109.2007.00390_16.x
SP  - 183
EP  - 185
PY  - 2007
ER  - 

TY  - JOUR
AU  - Droupy, S.
AU  - Austoni, E.
TI  - P-07 Surgery and Peyronie's Disease
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_7.x
DO  - doi:10.1111/j.1743-6109.2007.00390_7.x
SP  - 124
EP  - 127
PY  - 2007
ER  - 

TY  - JOUR
AU  - Goldstein, I.
AU  - Richardson, D.
TI  - MP-01 Female Sexual Health
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_8.x
DO  - doi:10.1111/j.1743-6109.2007.00390_8.x
SP  - 128
EP  - 132
PY  - 2007
ER  - 

TY  - JOUR
TI  - PP-06 General Issues in Sexual Medicine
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_18.x
DO  - doi:10.1111/j.1743-6109.2007.00390_18.x
SP  - 195
EP  - 202
PY  - 2007
ER  - 

TY  - JOUR
AU  - Angulo, J.
AU  - Jungwirth, A.
TI  - P-02 Pathophysiology of Sexual Dysfunctions
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_2.x
DO  - doi:10.1111/j.1743-6109.2007.00390_2.x
SP  - 108
EP  - 110
PY  - 2007
ER  - 

TY  - JOUR
AU  - Stief, C.
AU  - Minhas, S.
TI  - MP-04 Surgery, Peyronie’s Disease, and Priapism
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_11.x
DO  - doi:10.1111/j.1743-6109.2007.00390_11.x
SP  - 143
EP  - 147
PY  - 2007
ER  - 

TY  - JOUR
TI  - PP-05 Surgery, Priapism, and Peyronie's Disease
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_17.x
DO  - doi:10.1111/j.1743-6109.2007.00390_17.x
SP  - 185
EP  - 194
PY  - 2007
ER  - 

TY  - JOUR
AU  - Hatzichristou, D.
AU  - Wespes, E.
TI  - P-04 Pharmacology
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_4.x
DO  - doi:10.1111/j.1743-6109.2007.00390_4.x
SP  - 114
EP  - 117
PY  - 2007
ER  - 

TY  - JOUR
AU  - Chen, J.
AU  - Arver, S.
TI  - P-05 Ejaculatory Disorders
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_5.x
DO  - doi:10.1111/j.1743-6109.2007.00390_5.x
SP  - 118
EP  - 121
PY  - 2007
ER  - 

AU  - Kinoshita, Hideki
C7  - pp. 225-243
TI  - GAPDH and Probiotic Organisms
SN  - 9781118951118
UR  - https://doi.org/10.1002/9781118951149.ch12
DO  - doi:10.1002/9781118951149.ch12
SP  - 225-243
KW  - glyceraldehydes-3-phosphate dehydrogenase
KW  - Lactobacillus rhamnosus
KW  - moonlighting proteins
KW  - multi-binding properties
KW  - plasminogen binding
KW  - probiotic organisms
KW  - surface localization
PY  - 2007
AB  - Summary This chapter discusses the role of glyceraldehydes-3-phosphate dehydrogenase (GAPDH) in probiotics while also referring to other moonlighting proteins as the need arises. Probiotics do not produce toxic substances such as ammonia, indole, phenol, and nitrosamine, while probiotics can assimilate ammonia, inhibit the growth of toxic-substance-producing bacteria such as Escherichia coli, and adsorb and eliminate these substances. Lactobacillus rhamnosus GG (LGG) is one of the best-studied probiotic strains and many beneficial effects have been reported. LGG has been commercialized and consumed in a wide variety of food products and dietary supplements throughout the world for long time. Most reports about the multiple moonlighting functions of surface GAPDH in probiotics refer to adhesins. GAPDH has multi-binding properties. GAPDH may relate to stress response because some reports show expression of moonlighting proteins such as GAPDH increase under various stress conditions.
ER  - 

TY  - JOUR
AU  - Marsh, Shawn C.
AU  - Summers, Alicia
AU  - DeVault, Alicia
AU  - Guillermo Villalobos, J.
TI  - Lessons Learned from Developing a Trauma Consultation Protocol for Juvenile and Family Courts
JO  - Juvenile and Family Court Journal
JA  - Juv Fam Court J
VL  - 67
IS  - 3
SN  - 9781118951118
UR  - https://doi.org/10.1111/jfcj.12059
DO  - doi:10.1111/jfcj.12059
SP  - 5
EP  - 22
KW  - trauma
KW  - courts
KW  - juvenile
KW  - family
KW  - consultation
PY  - 2016
AB  - Abstract Juvenile and family courts hold a unique position among the many stakeholders that comprise a healing community for persons experiencing adversity or trauma. Specifically, judges and other court leaders can promote the implementation of screening for trauma, the alignment of appropriate and effective treatment for trauma when indicated, and the accountability of systems for coordination and support of such services. To that end, the National Council of Juvenile and Family Court Judges undertook a field-based project ? consisting of multiple semi-structured court surveys ? to elucidate the key features of a trauma-informed court and how to assist courts in becoming more trauma-responsive for both consumers and staff. With the assistance of courts in 11 pilot sites across the nation, the project has led to the development of a protocol called trauma consultation or trauma audit, which is outlined here. Our work in developing the consultation protocol highlighted the need to better understand (1) the prevalence and impact of secondary traumatic stress in court staff, (2) the potential for environment to contribute to traumatic stress reactions, and (3) the importance of consistent trauma screenings and subsequent use of findings. Practical suggestions for courts to become more trauma-informed are also provided.
ER  - 

TY  - JOUR
AU  - Melrose, James
C7  - 1800327
TI  - Functional Consequences of Keratan Sulfate Sulfation in Electrosensory Tissues and in Neuronal Regulation
JO  - Advanced Biosystems
JA  - Adv. Biosys.
VL  - 3
IS  - 4
SN  - 9781118951118
UR  - https://doi.org/10.1002/adbi.201800327
DO  - doi:10.1002/adbi.201800327
SP  - 1800327
KW  - Ampullae of Lorenzini
KW  - electrolocation
KW  - Keratan sulfate neural proteoglycans
KW  - KS sulfation
KW  - neuronal plasticity
KW  - sensory proteoglycans
PY  - 2019
AB  - Abstract Keratan sulfate (KS) is a functional electrosensory and neuro-instructive molecule. Recent studies have identified novel low sulfation KS in auditory and sensory tissues such as the tectorial membrane of the organ of Corti and the Ampullae of Lorenzini in elasmobranch fish. These are extremely sensitive proton gradient detection systems that send signals to neural interfaces to facilitate audition and electrolocation. High and low sulfation KS have differential functional roles in song learning in the immature male zebra song-finch with high charge density KS in song nuclei promoting brain development and cognitive learning. The conductive properties of KS are relevant to the excitable neural phenotype. High sulfation KS interacts with a large number of guidance and neuroregulatory proteins. The KS proteoglycan microtubule associated protein-1B (MAP1B) stabilizes actin and tubulin cytoskeletal development during neuritogenesis. A second 12 span transmembrane synaptic vesicle associated KS proteoglycan (SV2) provides a smart gel storage matrix for the storage of neurotransmitters. MAP1B and SV2 have prominent roles to play in neuroregulation. Aggrecan and phosphacan have roles in perineuronal net formation and in neuroregulation. A greater understanding of the biology of KS may be insightful as to how neural repair might be improved.
ER  - 
